Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: Prospective analysis of 435 liver biopsy pairs-Reference-Cited by-同舟云学术

Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: Prospective analysis of 435 liver biopsy pairs

Published:2014-01-16 Issue:3 Volume:59 Page:767-775
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Konerman Monica A.¹,Mehta Shruti H.²,Sutcliffe Catherine G.²,Vu Trang¹,Higgins Yvonne¹,Torbenson Michael S.³,Moore Richard D.¹²,Thomas David L.¹²,Sulkowski Mark S.¹

Affiliation:

1. Johns Hopkins Hospital/University School of Medicine; Baltimore MD

2. Johns Hopkins Bloomberg School of Public Health; Baltimore MD

3. Johns Hopkins Hospital Department of Pathology; Baltimore MD

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26741/fullpdf

Reference32 articles.

1. Hepatitis C in the HIV-infected person;Sulkowski;Ann Intern Med,2003

2. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group;Sherman;Clin Infect Dis,2002

3. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults;Sulkowski;AIDS,2007

4. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study);Rosenthal;AIDS,2003

5. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection;Bica;Clin Infect Dis,2001

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV and liver disease;Treatment and Management of Tropical Liver Disease;2025

2. Hepatitis B and C viral coinfection and associated factors among HIV-positive patients attending ART clinics of Afar regional state, northeast Ethiopia;PLOS ONE;2024-05-16

3. Safety and tolerability of OP-724 in patients with haemophilia and liver cirrhosis due to HIV/HCV coinfection: an investigator-initiated, open-label, non-randomised, single-centre, phase I study;BMJ Open Gastroenterology;2024-04

4. AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis;Hepatology;2024-03-15

5. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024;Saudi Journal of Gastroenterology;2024-01